Cancer prevention and treatment for people living with HIV
Consortium for Advancing Management and Prevention of Cancer in People with HIV
This program develops and runs clinical trials of new ways to prevent and treat cancers in people living with HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11406611 on NIH RePORTER |
What this research studies
You would be joining a network that runs clinical trials focused on cancers affecting people living with HIV, including prevention and treatment approaches for cancers like anal cancer. Trials are conducted at sites across the U.S., sub-Saharan Africa, and Latin America and involve medical follow-up, sample collection, and treatment or prevention procedures depending on the protocol. The consortium links clinics, laboratories, and community advocates so trial findings can be translated into better care. The program also supports training and community engagement to ensure trials meet patient needs and inform guidelines.
Who could benefit from this research
Good fit: Ideal candidates are people living with HIV who have, or are at high risk for, cancers studied by the consortium (for example anal cancer) and who can enroll at a participating site.
Not a fit: People without HIV or those whose cancer types are not included in the consortium's active trials are unlikely to receive direct benefit from this program's interventions.
Why it matters
Potential benefit: If successful, the program could lower cancer rates, improve treatment options, and reduce illness and deaths among people living with HIV.
How similar studies have performed: The AMC has run many trials (over 97 interventional trials with more than 10,000 participants) that have produced practice-changing evidence, so this effort builds on a proven track record.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.